sonar-pro
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.
{
  "id": "26cb4af6-c629-4b6a-b17d-bc3c2e9c74eb",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"answer\":\"PARTIAL\",\"note\":\"Based on available sources, the Philippines generally follows the International Conference on Harmonisation (ICH) guidelines for pharmaceutical stability testing[1][4]. The ICH Q1D guideline specifically addresses the use of bracketing and matrixing designs, allowing their application in stability studies with appropriate scientific justification and depending on the circumstances[4]. However, acceptance of these reduced designs can vary between regulatory authorities, and explicit, current Philippine FDA guidance confirming acceptance is not identified in the provided sources. Therefore, while the use of bracketing and matrixing is generally supported in countries adopting ICH guidelines, it is recommended to confirm acceptance with the Philippine FDA or through the latest national regulations before implementation[2][4].\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755743874,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 148,
    "prompt_tokens": 21,
    "total_tokens": 169,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.002,
      "request_cost": 0.006,
      "total_cost": 0.008
    }
  },
  "citations": [
    "https://humiditycontrol.com/blog/what-is-stability-testing/",
    "https://aapsopen.springeropen.com/articles/10.1186/s41120-023-00078-5",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-d-bracketing-and-matrixing-designs-stability-testing-drug-substances-and-drug-products-step-5_en.pdf",
    "https://database.ich.org/sites/default/files/ICH_Q1EWG_Step2_Draft_Guideline_2025_0411.pdf"
  ],
  "search_results": [
    {
      "title": "Stability Testing for Pharmaceuticals & More",
      "url": "https://humiditycontrol.com/blog/what-is-stability-testing/",
      "date": "2023-02-22",
      "last_updated": "2025-06-16"
    },
    {
      "title": "Stability considerations for drug-device combination products ...",
      "url": "https://aapsopen.springeropen.com/articles/10.1186/s41120-023-00078-5",
      "date": "2023-05-01",
      "last_updated": "2025-08-04"
    },
    {
      "title": "ich-q-1-r2-stability-testing-new-drug-substances-and-products ...",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "ich-q-1-d-bracketing-and-matrixing-designs-stability-testing ...",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-d-bracketing-and-matrixing-designs-stability-testing-drug-substances-and-drug-products-step-5_en.pdf",
      "date": null,
      "last_updated": "2025-04-16"
    },
    {
      "title": "STABILITY TESTING OF DRUG SUBSTANCES AND ...",
      "url": "https://database.ich.org/sites/default/files/ICH_Q1EWG_Step2_Draft_Guideline_2025_0411.pdf",
      "date": "2025-04-11",
      "last_updated": "2025-08-10"
    }
  ]
}